PharmaCyte Biotech PMCB
NASDAQ PMCB
$0.40 -0.01 (-1.63%)
As of: Oct 1, 2026 · 3:59 PM EDT

PharmaCyte Biotech (PMCB) EBT Margin (2010 - 2012)

Updated

PharmaCyte Biotech (PMCB) reported EBT Margin of -15121.52% for FY2013 (year ended Apr 30, 2013), down 11847.30 percentage points from -3274.22% in FY2012.

Analysis

PharmaCyte Biotech (PMCB) EBT Margin (2010 - 2012) Analysis & Trends

  • According to Business Quant data, EBT Margin came in at -3274.22% in FY2012 (-2829.75 pp) and -444.47% in FY2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 26.66%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 25.18%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -4.11%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 29.63%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 18.19%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 27.53%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -131.41%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -4.34%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 41.75%
10 PharmaCyte Biotech 4.40 Mn 4.40 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Oct 31, 2012 -6,617.83%
Jul 31, 2012 -8,826.58%
Apr 30, 2012 -9,135.55%
Jan 31, 2012 -2,198.90%
Oct 31, 2011 -2,202.94%
Jul 31, 2011 -3,133.18%
Apr 30, 2011 -1,035.53%
Jan 31, 2011 -41.99%
Oct 31, 2010 47.04%
Jul 31, 2010 -90.55%
API Access

PharmaCyte Biotech EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=PMCB&period=max&api_key=YOUR_API_KEY